Additionally, betavulgarin decreases the levels of proteins like c-myelocytomatosis (C-Myc), Nanog, and octamer-binding transcription factor 4 (Oct4), essential for self-renewal, and inhibits the Stat3/Sox2 signaling pathway, which is vital for cancer stem cell survival [100]. Here, SOX2 is linked to cancer.